SecBot SecBot
6-K ·Filed May 28, 2026

BHST

BIOHARVEST SCIENCES INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001723464-26-000032
Notable filing: 6-K
Actionable Insight • Neutral

No immediate trading catalyst. Monitor the AGM on June 25 for any unexpected shareholder dissent or board-level strategic updates. The CEO transition from Sobel to Rakib was already disclosed in prior filings — this circular confirms the slate.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
BHST ▼ -47.31% at T+60d
NEUTRAL call -47.31% · α vs SPY -49.04% · entry $3.90 → $2.06
Entry = T+0 close
May 28, 2026
via day close
T+1d
-1.03%
call -1.03% · α -1.27%
$3.86
settled 5mo ago
T+5d
-8.72%
call -8.72% · α -8.67%
$3.56
settled 5mo ago
T+20d
-28.97%
call -28.97% · α -25.83%
$2.77
settled 4mo ago
T+60d
-47.31%
call -47.31% · α -49.04%
$2.06
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

BioHarvest Sciences filed its annual meeting proxy circular on Form 6-K, setting the AGM for June 25, 2026. The filing is routine governance — director elections, auditor ratification, and executive compensation disclosure for FY2025. No material financial results, guidance, or strategic catalysts are included.

Key Facts

  • AGM scheduled for June 25, 2026 in Vancouver, BC.
  • Shareholders to elect Ilan Sobel, John Fiddick, and Anne Binder as Class I directors (term to 2029) and Yeheskel Levy as Class II director (term to 2027).
  • Ziv Haft (BDO) proposed for reappointment as auditor.
  • CEO transition: Ilan Sobel resigned as CEO and became director on April 29, 2026; Zaki Rakib appointed CEO on April 28, 2026.
  • 22,667,842 common shares outstanding as of May 19, 2026 record date.
  • Vivien Rakib beneficially owns 13.42% of outstanding shares.
  • No termination or change-of-control benefits for named executive officers.
  • Auditor fees for FY2025: ~$286,662 total (audit $169K, audit-related $45K, tax $17.5K, other $55K).
  • Equity incentive plan has 1,986,962 options outstanding and 1,395,717 shares available for future issuance.

Financial Impact

No material financial impact. Routine proxy filing with no earnings, guidance, or transaction.

Risk Factors

  • No material risks identified in this routine governance filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001723464-26-000032
Document: bhsc_6k.htm0001723464-26-000032
Document: bhsc_ex993.htm0001723464-26-000032
Document: 0001723464-26-000032-index-headers.html0001723464-26-000032
Document: 0001723464-26-000032-index.html0001723464-26-000032
Document: 0001723464-26-000032.txt0001723464-26-000032
14 reports for BHST
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+60▲ +49.52%May 14, 2026
Filters
Rows
Reports for BHST — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
6-K
BULLISH ★ 5/10
$1.75 $1.67▼ −4.18%▼ −4.64%$1.68 (−3.72%)
Oct 8, 2026
18d ago
6-K
NEUTRAL ★ 4/10
$1.50 $1.70▲ +13.71%▲ +13.99%$1.68 (+12.37%)
Sep 15, 2026
5w ago
6-K
NEUTRAL ★ 3/10
$1.66 $1.46▼ −12.05%▼ −14.61%$1.68 (+1.20%)
Sep 14, 2026
6w ago
6-K
NEUTRAL ★ 2/10
$1.78 $1.51▼ −14.93%▼ −17.04%$1.68 (−5.35%)
Jul 15, 2026
14w ago
6-K
NEUTRAL ★ 4/10
$2.85 $2.18▼ −23.51%▼ −22.53%$1.68 (−41.05%)
Jun 18, 2026
18w ago
6-K
NEUTRAL ★ 3/10
$3.26 $2.75▼ −15.64%▼ −13.98%$1.68 (−48.47%)
May 28, 2026
21w ago
6-K
NEUTRAL ★ 3/10
$3.90 $3.56▼ −8.72%▼ −8.67%$1.68 (−56.92%)
May 14, 2026
23w ago
6-K
NEUTRAL ★ 5/10
$4.16 $3.82▼ −8.17%▼ −7.46%$1.68 (−59.62%)
May 14, 2026
23w ago
6-K
BEARISH ★ 6/10
$4.16 $3.82▲ +8.17%▲ +7.46%$1.68 (+59.62%)
May 14, 2026
23w ago
6-K
NEUTRAL ★ 3/10
$4.16 $3.82▼ −8.17%▼ −7.46%$1.68 (−59.62%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 4h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026